MIM
GOSS icon

MetLife Investment Management’s Gossamer Bio GOSS Stock Holding History

MetLife Investment Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,071
Closed -$266K – 2802
2025
Q4 		$266K Sell
1,071
-198
-16% -$45.2K ﹤0.01% 2134
2025
Q3 		$267K Sell
1,269
-179
-12% -$31.6K ﹤0.01% 2149
2025
Q2 		$142K Buy
+1,448
New +$126K ﹤0.01% 2364
2023
Q1 		– Sell
-74
Closed -$12.8K – 2802
2022
Q4 		$12.8K Sell
74
-359
-83% -$236K ﹤0.01% 2826
2022
Q3 		$415K Buy
433
+48
+12% +$47.7K ﹤0.01% 1769
2022
Q2 		$258K Sell
385
-56
-13% -$34.7K ﹤0.01% 2133
2022
Q1 		$306K Buy
441
+158
+56% +$122K ﹤0.01% 2081
2021
Q4 		$256K Buy
283
+74
+35% +$70.3K ﹤0.01% 1906
2021
Q3 		$210K Sell
209
-97
-32% -$71.4K ﹤0.01% 2072
2021
Q2 		$199K Buy
306
+167
+120% +$116K ﹤0.01% 2180
2021
Q1 		$103K Sell
139
-148
-52% -$119K ﹤0.01% 2248
2020
Q4 		$222K Hold
287
– – ﹤0.01% 1922
2020
Q3 		$285K Hold
287
– – ﹤0.01% 1656
2020
Q2 		$299K Buy
287
+41
+17% +$41.3K ﹤0.01% 1656
2020
Q1 		$199K Hold
246
– – ﹤0.01% 1698
2019
Q4 		$307K Hold
246
– – ﹤0.01% 1733
2019
Q3 		$330K Buy
246
+121
+97% +$192K ﹤0.01% 1653
2019
Q2 		$221K Buy
+125
New +$191K ﹤0.01% 1972

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

MetLife Investment Management's GOSS Position: Q1 2026 in Review

MetLife Investment Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 1,071 shares — an estimated $266K sold.

MetLife Investment Management first reported a position in GOSS in Q2 2019 and held it in 18 quarters. The position peaked at $415K in Q3 2022. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • MetLife Investment Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 1,071 Gossamer Bio shares in Q1 2026, an estimated $266K.
  • MetLife Investment Management first reported a position in Gossamer Bio in Q2 2019 and held it in 18 quarters.
  • MetLife Investment Management's Gossamer Bio position peaked at $415K in Q3 2022.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.